Can I Use Semaglutide for Weight Loss? Exploring the Benefits of a Groundbreaking Medication

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed to help people with type 2 diabetes manage blood sugar levels. Clinical trials have demonstrated that semaglutide can produce significant weight loss results, with some patients losing 15% or more of their body weight over one year. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies, making this medication available across all 50 states without insurance requirements.

How Semaglutide Works for Weight Loss

Semaglutide operates by mimicking a natural hormone called glucagon-like peptide-1 (GLP-1) that your body produces after eating. This medication binds to GLP-1 receptors in your brain, particularly in areas that regulate appetite and satiety signals. By activating these receptors, semaglutide helps reduce hunger cues, increase feelings of fullness, and slow how quickly food moves through your digestive system.

The appetite-suppressing effect typically begins within the first few weeks of treatment, though individual responses vary based on genetics, metabolism, and lifestyle factors. Many patients report that food cravings diminish significantly, making it easier to consume fewer calories without feeling deprived. This biological mechanism differs from older weight loss medications because it addresses the root cause of overeating—dysregulated hunger signals—rather than simply reducing calorie absorption or increasing energy expenditure.

Clinical Evidence Supporting Semaglutide Efficacy

Multiple randomized controlled trials have established semaglutide's effectiveness for weight management. The STEP trials, which enrolled thousands of participants without diabetes, showed that people taking semaglutide 2.4 mg weekly lost approximately 15% of their baseline body weight compared to just 2.6% in the placebo group over 68 weeks. Importantly, participants also demonstrated improvements in cardiovascular risk factors, including reductions in blood pressure and triglyceride levels.

Real-world data from PlexusDx patients reflects similar outcomes, with many individuals achieving meaningful weight loss within 3-6 months of consistent treatment. The medication's effects compound over time, particularly when combined with sustainable dietary changes and regular physical activity. Genetic variations in your GLP-1 receptor can influence how responsive you'll be to semaglutide, which is why PlexusDx offers the Precision Peptide Genetic Test to identify your individual peptide pathway profile.

Semaglutide Injection vs. Oral Options: What Suits You

PlexusDx offers both compounded semaglutide injection and oral formulations to match your lifestyle and preferences. The injection form, administered weekly, provides consistent absorption and typically requires lower doses to achieve therapeutic results, at $189/mo month-to-month, or from $149/mo on the 6-month plan. Oral semaglutide requires daily dosing and is $289/mo month-to-month, or from $249/mo on the 6-month plan due to lower bioavailability, meaning your body absorbs less of the medication when taken by mouth.

Injection therapy generally produces faster and more predictable weight loss outcomes because the medication bypasses the digestive system and enters the bloodstream directly. Many patients prefer weekly injections because they offer convenience and flexibility—you inject once per week at home without dietary restrictions. However, some individuals prefer oral medications due to needle anxiety or scheduling preferences. Your dose may need to go up as your body adapts, but your price won't change—PlexusDx maintains flat monthly pricing regardless of dose adjustments.

Getting Started With PlexusDx Semaglutide Therapy

Beginning semaglutide at PlexusDx starts with a simple telehealth consultation where a licensed provider reviews your health history, weight loss goals, and current medications to ensure safety and appropriateness. PlexusDx compounds all medications at licensed 503A pharmacies—facilities that adhere to strict FDA standards for sterility, potency, and quality. Your prescription ships discreetly to your home across all 50 states without requiring insurance, and HSA and FSA accounts cover the cost.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO (rs9939609) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Safety, Side Effects, and What to Expect

The most commonly reported side effects during early semaglutide therapy include mild nausea, reduced appetite for certain foods, and occasional constipation—effects that typically diminish as your body adapts over 2-4 weeks. These effects are generally mild compared to older weight loss medications and often represent the medication working as intended by regulating your appetite signals. Serious side effects are rare but can include severe pancreatitis or thyroid concerns; PlexusDx providers screen for contraindications during your initial consultation.

Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not use semaglutide. Pregnancy is not recommended during treatment because semaglutide's effects on fetal development remain under study. PlexusDx ensures that each patient receives provider oversight throughout treatment, with check-ins to monitor progress, adjust dosing, and address any emerging concerns. Most patients experience weight loss beginning within 2-4 weeks, with maximal effects accumulating over 12-16 weeks of consistent therapy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Who is a good candidate for semaglutide weight loss therapy?

Semaglutide is appropriate for adults with a BMI of 30 or higher, or BMI of 27 or higher with weight-related health conditions such as high blood pressure or type 2 diabetes. PlexusDx providers assess your complete health profile during your telehealth consultation to confirm suitability and identify any contraindications before treatment begins.

How much weight can I expect to lose with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What is the cost of semaglutide at PlexusDx?

Compounded semaglutide injection at PlexusDx is $189/mo month-to-month (or $149/mo on the 6-month plan) across three commitment tiers, with no insurance required and full HSA/FSA eligibility. Your dose may need to go up as treatment progresses, but your price won't—PlexusDx maintains flat monthly pricing regardless of dose adjustments.

Are there side effects, and how long do they last?

Initial side effects may include mild nausea, constipation, or reduced appetite, typically resolving within 2-4 weeks as your body adjusts. Serious side effects are uncommon; PlexusDx providers screen for contraindications upfront and monitor your progress throughout treatment to address any emerging concerns promptly.

How does the Precision Peptide Genetic Test help with semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.